tradingkey.logo

Revvity Inc

RVTY
查看詳細走勢圖
96.200USD
-0.060-0.06%
收盤 12/19, 16:00美東報價延遲15分鐘
10.97B總市值
48.35本益比TTM

Revvity Inc

96.200
-0.060-0.06%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.06%

5天

-4.27%

1月

+2.32%

6月

+1.27%

今年開始到現在

-13.81%

1年

-14.53%

查看詳細走勢圖

TradingKey Revvity Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Revvity Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名36/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價111.72。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Revvity Inc評分

相關信息

行業排名
36 / 208
全市場排名
112 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 20 分析師
買入
評級
111.718
目標均價
+11.95%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Revvity Inc亮點

亮點風險
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
高分紅
公司屬於高分紅公司,最新股息支付率12.14%
穩定分紅
公司5年內持續分紅,最新股息支付率12.14%
估值合理
公司最新PE估值48.37,處於3年歷史合理位
機構減倉
最新機構持股117.06M股,環比減少7.01%
肯·費雪持倉
明星投資者肯·費雪持倉,最新持倉15.56K股

Revvity Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Revvity Inc簡介

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
公司代碼RVTY
公司Revvity Inc
CEOSingh (Prahlad R)
網址https://www.revvity.com/

常見問題

Revvity Inc(RVTY)的當前股價是多少?

Revvity Inc(RVTY)的當前股價是 96.200。

Revvity Inc 的股票代碼是什麼?

Revvity Inc的股票代碼是RVTY。

Revvity Inc股票的52週最高點是多少?

Revvity Inc股票的52週最高點是128.285。

Revvity Inc股票的52週最低點是多少?

Revvity Inc股票的52週最低點是81.360。

Revvity Inc的市值是多少?

Revvity Inc的市值是10.97B。

Revvity Inc的淨利潤是多少?

Revvity Inc的淨利潤為270.38M。

現在Revvity Inc(RVTY)的股票是買入、持有還是賣出?

根據分析師評級,Revvity Inc(RVTY)的總體評級為買入,目標價格為111.718。

Revvity Inc(RVTY)股票的每股收益(EPS TTM)是多少

Revvity Inc(RVTY)股票的每股收益(EPS TTM)是1.990。
KeyAI